GVR Report cover Insufflation Devices Market Size, Share & Trends Report

Insufflation Devices Market Size, Share & Trends Analysis Report By Application (Laparoscopic Surgery, Bariatric Surgery, Cardiac Surgery), By End Use (Hospitals, Ambulatory Surgical Centers), And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68038-347-8
  • Number of Pages: 105
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview                                           

The global insufflation devices market size was valued at USD 2.31 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028. The demand for insufflation devices is increasing owing to the technological advancements in surgery, the increasing number of surgical cases, and the rising prevalence of uterine fibroids, obesity, and heart disorders across the globe. The increasing incidence of obesity due to a sedentary lifestyle and an increase in the intake of energy-dense foods that are high in fat and sugar is one of the leading factors contributing to the market growth. For instance, according to the CDC, obesity prevalence in the U.S. has increased from 30.5% in 2000 to 42.4% in 2018.

U.S. insufflation devices market size, by application, 2018 - 2028 (USD Million)

The use of insufflation devices helps to maintain the pneumoperitoneum during bariatric surgery and lower the risk of clinical complications. Furthermore, they help to maintain favorable abdominal pressure conditions, thereby reducing the operating time and the undesirable effects of CO2 pneumoperitoneum. Thus, healthcare professionals prefer to use insufflation devices during laparoscopic, bariatric, cardiac, and other surgeries. These factors are anticipated to propel the market growth over the forecast period. The increasing number of laparoscopic surgeries performed across the globe due to the benefits offered by them is expected to increase the use of insufflation devices. For instance, according to a report published by AHA journals in 2017, more than 2 million laparoscopic surgical procedures are performed per year in the U.S. The overall mortality of laparoscopic surgery is low, ranging from 0.3% to 1.8%, as compared to traditional surgeries. Laparoscopic surgery is frequently utilized in higher-risk patient groups, including the elderly, obese patients, and those with preexisting conditions, including cardiovascular and pulmonary diseases. According to the CDC, around 600,000 hysterectomies are performed every year in the U.S., and around 20 million U.S. women have had a hysterectomy. Such cases are expected to increase the demand for insufflation devices.

The increasing prevalence of obese people having a BMI of 35-39 with specific significant health problems, such as type 2 diabetes, sleep apnea, and high blood pressure, is a high-impact driver for the market as insufflation devices are utilized in bariatric surgery. For instance, according to the American Society for Metabolic and Bariatric Surgery (ASMBS), the number of bariatric surgeries increased from 158,000 in 2011 to 256,000 in 2018. Furthermore, growing awareness about bariatric surgery has increased the demand for insufflation devices as an effective therapy.

The use of insufflation devices in cardiac surgery to reduce postoperative complications, such as cerebral injury, myocardial dysfunction, and dysrhythmias, is expected to drive the market during the forecast period. As per the estimates by the CDC, around 655,000 Americans die from heart disease every year. Cardiac surgery reduces the risk of dying of heart disease, which indirectly amplifies the demand for insufflation devices.

Application Insights

The laparoscopic surgery segment held the largest share of over 35.0% in 2020 and is anticipated to witness considerable growth over the forecast period. The increasing cases of different laparoscopic surgical techniques, such as laparoscopic cholecystectomy, laparoscopic hernia repair, laparoscopic splenectomy, and laparoscopic hepatectomy, across the globe, are driving the segment. The multiple benefits of laparoscopic surgery include reduced postoperative pain, improved cosmetic results, enhanced patient satisfaction, and reduced hospital stay. There is also an increase in the number of emergency operations performed laparoscopically. Since insufflation devices are majorly used for performing laparoscopic surgeries, therefore, such factors are expected to surge the segment growth.

The other surgeries segment is expected to expand at the highest CAGR of 7.1% from the forecast period. The increasing number of surgeries such as carotid artery surgery, cataract surgery, and tonsillectomy is expected to drive the segment. For instance, as per the American Academy of Ophthalmology, around 24.4 million people aged 40 years are affected by cataracts. Furthermore, the increasing prevalence of stroke has led to an increase in carotid artery surgery. According to the AHA journals, The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomatic Carotid Atherosclerosis Study (ACAS) said that carotid artery surgery is better than medical therapy alone, thus fueling the market growth.

End-use Insights

The hospitals segment held the largest share of more than 60.0% in 2020. The growth of this segment can be attributed to the upsurge in surgical procedures globally because of a sedentary lifestyle, bad dietary habits, and rising cancer cases, which require the use of insufflation devices. Furthermore, the availability of technologically advanced insufflation devices, such aspersufflator, which is designed mainly for laparoscopy and carbon dioxide laser endoscopic surgery, will further enhance the market growth during the forecast period. In addition, hospital institutions are considered to be the large buyers of insufflation devices having long-term contracts with suppliers, which enhances the negotiating power of suppliers and creates a market for after-sales services.

Global insufflation devices market share, by end use, 2020 (%)

The ambulatory surgical centers segment is anticipated to register the fastest growth rate of 7.4% over the forecast period. An increase in the demand for minimally invasive surgeries, such as laparoscopic surgery, and increasing adoption of technologically advanced medical products by ambulatory surgical centers are a few factors fueling the market growth. Moreover, the cost-effective and speedier treatment, along with high-quality surgery care, might increase the number of outpatients’ admission owing to which the demand for insufflation devices is expected to increase.

Regional Insights

North America dominated the market with as hare of over 35.0% in 2020 and is expected to witness considerable growth over the forecast period. The growth of this regional market is attributed to the increase in the prevalence of laparoscopic surgeries, such as hysterectomy and cholecystectomy, and a rise in the demand for minimally invasive procedures. Technological advancements are also contributing to the growth of the market in North America. Therefore, North America is expected to dominate the market over the forecast period.

The Asia Pacific market is anticipated to witness the fastest growth over the forecast period. The increasing prevalence of obesity and heart disorders, along with unmet demand for effective and long-term treatment solutions, is expected to present significant growth opportunities for insufflation devices in this region. Moreover, the rising preference for clinical trials and high R&D investments by global market players owing to their low-cost structure is high-impact rendering drivers for the market in the Asia Pacific region. Rising awareness regarding minimally invasive surgeries and patient compliance with outpatient surgery are expected to fuel the market growth in this region.

Key Companies & Market Share Insights

Key players are involved in adopting strategies such as mergers & acquisitions, partnerships, and the launch of new technologically advanced products and services to strengthen their foothold in the market. Key players are significantly investing in research and development to manufacture technologically advanced products. Some prominent players in the global insufflation devices market include:

  • Fujifilm

  •  Medtronic

  •  Stryker

  •  BD

  • Olympus

  •  B. Braun Melsungen

  •  Smith & Nephew

  • Karl Storz

  • Steris


  • Richard Wolf

Insufflation Devices Market Report Scope

Report Attribute


Market size value in 2021

USD 2.45 billion

Revenue forecast in 2028

USD 3.76 billion

Growth Rate

CAGR of 6.3% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; UAE; Saudi Arabia

Key companies profiled

Fujifilm; Medtronic; Stryker; BD; Olympus; B. Braun Melsungen; Smith & Nephew; Karl Storz; Steris; CONMED; Richard Wolf

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global insufflation devices market report on the basis of application, end use, and region:

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Laparoscopic Surgery

    • Bariatric Surgery

    • Cardiac Surgery

    • Other Surgeries

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.